Table 4.
In Vitro Differentiation of CD4+ IRF-2+/− and IRF-2−/− T Cells
| IRF-2+/− | IRF-2−/− | |||||||
|---|---|---|---|---|---|---|---|---|
| IFN-γ | IL-4 | IFN-γ | IL-4 | |||||
| Secondary stimulus: | − | anti-CD3 | − | anti-CD3 | − | anti-CD3 | − | anti-CD3 |
| Primary stimulus | ||||||||
| Anti-CD3 | <0.016 | 6 | <0.0075 | <0.0075 | <0.016 | <0.016 | <0.0075 | <0.0075 |
| Anti-CD3 + IL-4 + anti–IL-12 | <0.016 | 13 | <0.0075 | 65 | <0.016 | 50 | <0.0075 | 63 |
| Anti-CD3 + IL-12 + anti–IL-4 | 1 | 1,260 | <0.0075 | <0.0075 | <0.016 | 600 | <0.0075 | <0.0075 |
Pooled naive CD4+ T cells were purified from spleens and LNs of IRF-2−/− and control IRF-2+/− mice. The cells were stimulated with immobilized anti-CD3 and the indicated (primary stimulus) cytokines and antibody for 96 h, then washed and transferred to wells without anti-CD3. After an additional 48 h, the cells were washed and restimulated in the presence or absence of anti-CD3 (secondary stimulus). SNs were harvested after 24 h and analyzed in triplicate for IFN-γ and IL-4 production (in ng/ml) by ELISA. In all cases, the SD of these determinations was <10%.